Mei Pharma Inc (NQ: MEIP )
3.140
+0.090
(+2.95%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Mei Pharma Inc
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240514694904/en/2130429/5/GPM_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20240509996400/en/2125115/22/MEI_Logo_Horizontal.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240215141307/en/2036231/5/GPM_Logo_Color_RGB.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
February 13, 2024
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20231214381102/en/1970761/5/GPM_Logo_Color.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
November 09, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
November 08, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023
November 02, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
November 01, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Recommends Stockholders Not to Consent
October 17, 2023
From MEI Pharma
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Adopts Limited-Duration Stockholder Rights Plan
October 02, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actions
September 28, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights
September 26, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car
September 18, 2023
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230723148389/en/1847716/22/MEI_Logo_Horizontal.jpg)
From MEI Pharma, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://mms.businesswire.com/media/20230716971502/en/1842194/22/MEI_Logo_Horizontal.jpg)
From MEI Pharma, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230713041559/en/1841197/22/MEI_Logo_Horizontal.jpg)
MEI Pharma Postpones Special Meeting of Shareholders
July 13, 2023
From MEI Pharma, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.